Clinical Trials Browser

Withdrawn × INDUSTRY × Idarubicin × Clear all

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT00967512 2014-09-18

Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute